Frontlight ResearchEarly access
Trial site
Advanced Memory Research Institute of NJ
- 1running trial
- 5closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Mild cognitive impairment2 trials
- Phase
- Phase 34 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Terminated3 trials
- Completed2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Cassava Sciences, Inc.3 trials
- Novo Nordisk A/S2 trials
- ProMis Neurosciences, Inc1 trial
Running trials
Active, not recruiting
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
Closed trials
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Terminated
Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Site data: ClinicalTrials.govUpdated 12 Nov 2026